Skip to content

Clinical study of fecal bacteria transplantation in the treatment of refractory constipation.

Clinical study of fecal bacteria transplantation in the treatment of refractory constipation.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOB-15006348
Enrollment
Unknown
Registered
2015-04-17
Start date
2015-04-01
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory constipation

Interventions

Fecal bacteria transplantation cobine with mosapride treatment group:Fecal bacteria transplantation and drug treatment
mosapride treatment group:Drug treatment

Sponsors

The First Affiliated Hospital of the Fourth Military Medical University of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Rome III, should include two or more than 2 following items: (1) at least 25% bowel struggle; (2) at least 25% bowel dry or hard dung; (3) at least 25% defecation have different sense; (4) at least 25% defecation anorectal obstruction and/or blockage; (5) at least 25% required manual defecation (i.e., finger help defaction, pelvic support); (6) leas than 3 times per week. 2. Rarely appeared loose stools without laxatives; 3. Do not meet the diagnostic criteria for irritable bowel syndrome.

Exclusion criteria

Exclusion criteria: 1. Three months prior to the current study, patients have myocardial infarction or unstable angina pectoris history; 2. Prepare pregnant, pregnant and nursing women; 3. Patients with malignant disease; 4. Patients with nervous system diseases; 5. Heart, liver, renal insufficiency patients; 6. Long term steroids treatment; 7. Patients with thyroid disease; 8. Patients with adrenal diseases; 9. People with diabetes; 10. Patients with hypertensive patients; 11. Patients with hyperlipidemia patients; 12. Patients with small intestinal malabsorption.

Design outcomes

Primary

MeasureTime frame
The percentage of weekly complete spontaneous bowel movement (SCBM) more than 3 times;

Secondary

MeasureTime frame
The percentage of SCBM increase more than or equal to 1 times a week;The frequency of defecation;Life quality assessment;The structural and quantity alterations of intestinal flora pre- and after fecal transplantation.;Anxiety;Depression;

Countries

China

Contacts

Public ContactWu, Kaichun
kaicwu@fmmu.edu.cn+86 13709218743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026